A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study

Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeutic option for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability is warranted. In this multicenter prospective, observationa...

Full description

Saved in:
Bibliographic Details
Published in:JBMR Plus
Main Authors: Minisola, Salvatore, Vargas, Antonio P, Letizia Mauro, Giulia, Bonet Madurga, Fernando, Adami, Giovanni, Black, Dennis M, Qizilbash, Nawab, Blanch‐Rubió, Josep
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2021
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260812/
https://ncbi.nlm.nih.gov/pubmed/34258506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10510
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items